MALVERN, Pa., March 12, 2025 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today that a post hoc data analysis of a Phase 3 clinical trial of XIAFLEX® (collagenase clostridium histolyticum, or ...
Pfizer's new drug for claw hand may be used by men with bent phallus. Feb. 5, 2010— -- A new drug for claw hand, a condition that causes bent fingers, may serve double-duty as a ...
MALVERN, PA — Endo, Inc. (OTCQX: NDOI) revealed new insights from a post hoc data analysis of its Phase 3 clinical trial of XIAFLEX® (collagenase clostridium histolyticum, or CCH) for the treatment of ...
MIAMI -- Men receiving collagenase clostridium histolyticum (CCH; Xiaflex) injections for Peyronie's disease had similar levels of overall satisfaction to surgery, and with fewer adverse effects, but ...
The MarketWatch News Department was not involved in the creation of this content. MALVERN, Pa., May 7, 2024 /CNW/ -- Endo, Inc. announced today that three new presentations related to Peyronie's ...
Endo is taking its Peyronie's disease campaign from the vegetable aisle to the pool hall. Having initially relied on wonky veg to discuss the men’s health condition, the drugmaker has now brought four ...
A new :90 spot for Xiaflex begins with a couple watching the brand’s groundbreaking 2021 ad, with a carrot substituting for the curved penis of Peyronie’s disease patients. During the commercial, a ...
Endo is ramping up the next phase of its Dupuytren's contracture marketing drive. Not long after running its first branded ad for Xiaflex in the indication, the drugmaker has dubbed September the ...
September 17, 2009 — The US Food and Drug Administration (FDA)'s Arthritis Advisory Committee voted unanimously (12 to 0) yesterday to recommend approval of collagenase clostridium histolyticum ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback